| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | 144315-07-1 | CV 11464 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 2 | 886208-65-7 | MW01-2-151SRM |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 3 | 1190598-60-7 | CFMMC |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 4 | 1208552-99-1 | CFMB |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 5 | 1263283-43-7 | Dexrazoxane hydrochloride |
≥98% | | 询价 |
| 6 | 639507-03-2 | CFM-5 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 7 | 331458-02-7 | CFM-4 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 8 | 1819357-88-4 | CFM-184 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 9 | 1380448-60-1 | CFM-1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 10 | 868540-16-3 | CFLZ-567 |
≥98% | | 询价 |
| 11 | 247068-85-5 | CFLZ-171 TFA salt |
≥98% | | 询价 |
| 12 | 1610677-37-6 | CFI-402257 HCl |
≥98% | | 询价 |
| 13 | 1610759-22-2 | CFI-402257 |
≥98% | | 询价 |
| 14 | 1430741-35-7 | CFI-401870 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 15 | 28008-54-0 | Daunosamnyl-daunorubicin |
≥98% | | 询价 |
| 16 | 1338793-07-9 | CFI-400936 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 17 | 1169211-37-3 | CFI-400437 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 18 | 127-40-2 | Lutein |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 19 | 1808160-52-2 | CF53 free base |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 20 | 476148-82-0 | MCI-225 hydrochloride hydrate |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 21 | 135991-48-9 | MCI-225 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 22 | 319425-66-6 | CF-1743 |
≥98% | | 询价 |
| 23 | 163042-96-4 | Namodenoson(2 Cl-IB-MECA CF102) |
≥98% | | 询价 |
| 24 | 73544-48-6 | Lycopsamine-1-acetate |
≥98% | | 询价 |
| 25 | 205187-53-7 | CX-157 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 26 | 23696-28-8 | Olaquindox |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 27 | 1431520-49-8 | CX14442 Sodium |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 28 | 1256341-22-6 | CX08005 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 29 | 957890-42-5 | CX04328 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 30 | 1144044-02-9 | CWP232228 sodium |
≥98% | | 询价 |
| 31 | 1505452-80-1 | CWHW-117 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 32 | 2062-78-4 | Pimozide |
≥98% | | 询价 |
| 33 | 63075-47-8 | Fepradinol |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 34 | 1695560-60-1 | CWHM-505 HCl |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 35 | 1134613-19-6 | CW 008 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 36 | 752222-83-6 | CVT-6883 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 37 | 172430-48-7 | CVT-3369 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 38 | 172430-50-1 | CVT-3248 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 39 | 199986-75-9 | CVT-313 |
≥98% | | 询价 |
| 40 | 342419-10-7 | CVT-2759 |
≥98% | | 询价 |
| 41 | 5294-61-1 | CVT-2738 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 42 | 172430-44-3 | CVT-2551 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 43 | 162712-35-8 | CVT-2513 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 44 | 172430-46-5 | CVT-2512 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 45 | 128835-92-7 | Lipofectin |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 46 | 1018674-83-3 | CVT-11127 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 47 | 1005334-57-5 | CVT-10216 |
≥98% | | 询价 |
| 48 | 55778-02-4 | WZ 811 |
| 5mg, 10mg, 50mg, 100mg | 询价 |
| 49 | 1219104-20-7 | LQB-118 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 50 | 191744-13-5 | CX614 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 51 | 118074-08-1 | Alterporriol C |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 52 | 215923-54-9 | CX546 |
≥98% | | 询价 |
| 53 | 1009821-06-0 | CX-5011 |
≥98% | | 询价 |
| 54 | 1040526-12-2 | LP-533401 HCl |
≥98% | | 询价 |
| 55 | 10285-07-1 | Lycopsamine |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 56 | 839673-52-8 | Cevoglitazar |
≥98% | | 询价 |
| 57 | | SS1020 |
≥98% | | 询价 |
| 58 | 1320211-70-8 | Pralatrexate,(R)- |
≥98% | | 询价 |
| 59 | 1187594-09-7 | Baricitinib |
| 2mg, 5mg, 10mg | 询价 |
| 60 | 849550-05-6 | Cevipabulin |
≥98% | | 询价 |
m.cnreagent.com